KALA · Insider Trading
KALA BIO, Inc. Common Stock
Every open-market purchase and sale reported by KALA officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-22 | David E. Lazar | Chief Executive Officer | J | — | — |
| 2025-11-26 | David E. Lazar | Chief Executive Officer | A | — | — |
| 2025-10-24 | Romulus K Brazzell | SEE REMARKS | Sell | −46,748 | −$38.80K |
| 2025-10-24 | Mark T Iwicki | Director | Sell | −154,894 | −$125.46K |
| 2025-10-24 | Darius Kharabi | CHIEF BUSINESS OFFICER | Sell | −20,806 | −$17.27K |
| 2025-10-24 | Mary Reumuth | CHIEF FINANCIAL OFFICER | Sell | −33,197 | −$27.54K |
| 2025-10-24 | Todd Bazemore | Director | Sell | −47,768 | −$39.65K |
| 2025-10-02 | BAKER BROS. ADVISORS LP | — | Sell | −2,921,632 | −$4.23M |
| 2025-09-02 | Todd Bazemore | SEE REMARKS | A | +180,000 deriv. | — |
| 2025-06-26 | Darius Kharabi | CHIEF BUSINESS OFFICER | Sell | −4,511 | −$18.09K |
| 2025-06-26 | Romulus K Brazzell | SEE REMARKS | Sell | −5,251 | −$21.06K |
| 2025-06-26 | Mary Reumuth | CHIEF FINANCIAL OFFICER | Sell | −3,631 | −$14.56K |
| 2025-06-26 | Mark T Iwicki | Director | Sell | −13,227 | −$53.04K |
| 2025-06-26 | Todd Bazemore | SEE REMARKS | Sell | −4,058 | −$16.27K |
| 2025-06-17 | Howard B Rosen | Director | A | +2,450 | — |
| 2025-06-17 | Mark T Iwicki | Director | A | +2,450 | — |
| 2025-06-17 | C. Daniel Myers | Director | A | +2,450 | — |
| 2025-06-17 | Andrew I Koven | Director | A | +3,050 | — |
| 2025-06-17 | Gregory D Perry | Director | A | +2,450 | — |
| 2025-06-17 | Marjan Farid | Director | A | +2,450 | — |
| 2025-06-05 | Mark T Iwicki | Director | Sell | −10,866 | −$40.64K |
| 2025-06-04 | Romulus K Brazzell | SEE REMARKS | Sell | −3,687 | −$13.79K |
| 2025-06-04 | Mary Reumuth | CHIEF FINANCIAL OFFICER | Sell | −2,850 | −$10.66K |
| 2025-06-04 | Todd Bazemore | SEE REMARKS | Sell | −3,390 | −$12.68K |
| 2025-06-04 | Mark T Iwicki | Director | Sell | +10,866 | +$40.64K |
| 2025-06-04 | Darius Kharabi | CHIEF BUSINESS OFFICER | Sell | −730 | −$2.73K |
| 2025-03-10 | Todd Bazemore | SEE REMARKS | A | +45,200 deriv. | — |
| 2025-01-10 | Romulus K Brazzell | SEE REMARKS | — | — | — |
| 2025-01-07 | Mark T Iwicki | CHIEF EXECUTIVE OFFICER | MIXED | +16,321 | −$44.09K |
| 2025-01-07 | Romulus K Brazzell | SEE REMARKS | MIXED | +7,654 | −$18.66K |
| 2025-01-07 | Darius Kharabi | CHIEF BUSINESS OFFICER | MIXED | +8,079 | −$15.42K |
| 2025-01-07 | Mary Reumuth | CHIEF FINANCIAL OFFICER | MIXED | +8,394 | −$13.02K |
| 2025-01-07 | Todd Bazemore | SEE REMARKS | MIXED | +8,107 | −$15.21K |
| 2024-12-31 | Julian Baker | 10%+ Owner | Buy | +1,242,236 | +$8.00M |
| 2024-06-27 | Darius Kharabi | CHIEF BUSINESS OFFICER | Sell | −5,158 | −$24.50K |
| 2024-06-27 | Todd Bazemore | SEE REMARKS | Sell | −4,653 | −$22.10K |
| 2024-06-27 | Mary Reumuth | CHIEF FINANCIAL OFFICER | Sell | −4,163 | −$19.77K |
| 2024-06-27 | Mark T Iwicki | CHIEF EXECUTIVE OFFICER | Sell | −15,168 | −$72.05K |
| 2024-06-27 | Romulus K Brazzell | SEE REMARKS | Sell | −5,489 | −$26.07K |
| 2024-06-12 | Gregory D Perry | Director | A | +1,400 | — |
| 2024-06-12 | Marjan Farid | Director | A | +1,400 | — |
| 2024-06-12 | Andrew I Koven | Director | A | +1,750 | — |
| 2024-06-12 | Mark S. Blumenkranz | Director | A | +1,400 | — |
| 2024-06-12 | Howard B Rosen | Director | A | +1,400 | — |
| 2024-06-12 | C. Daniel Myers | Director | A | +1,400 | — |
| 2024-06-03 | Romulus K Brazzell | SEE REMARKS | Sell | −2,002 | −$12.19K |
| 2024-06-03 | Darius Kharabi | CHIEF BUSINESS OFFICER | Sell | −231 | −$1.41K |
| 2024-06-03 | Todd Bazemore | SEE REMARKS | Sell | −2,093 | −$12.75K |
| 2024-06-03 | Mark T Iwicki | CHIEF EXECUTIVE OFFICER | Sell | −7,392 | −$45.02K |
| 2024-06-03 | Mary Reumuth | CHIEF FINANCIAL OFFICER | Sell | −1,786 | −$10.88K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Julian Baker | 10%+ Owner | 2,370 | $441 |
| Mark T Iwicki | Director | 2,071 | $386 |
| BAKER BROS. ADVISORS LP | — | 930 | $173 |
| Darius Kharabi | CHIEF BUSINESS OFFICER | 835 | $155 |
| Romulus K Brazzell | SEE REMARKS | 719 | $134 |
| Todd Bazemore | SEE REMARKS | 719 | $134 |
| Mary Reumuth | CHIEF FINANCIAL OFFICER | 578 | $108 |
| Andrew I Koven | Director | 339 | $63 |
| Howard B Rosen | Director | 330 | $61 |
| Gregory D Perry | Director | 267 | $50 |
| C. Daniel Myers | Director | 207 | $39 |
| Marjan Farid | Director | 205 | $38 |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the KALA quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.